Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

BACKGROUND: There is limited information regarding the optimal third-line therapy for managing type 2 diabetes mellitus (T2DM) that is inadequately controlled using dual combination therapy. This study assessed the efficacy and safety of pioglitazone or glimepiride when added to metformin plus alogl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeong Mi, Kim, Sang Soo, Kim, Jong Ho, Kim, Mi Kyung, Kim, Tae Nyun, Lee, Soon Hee, Lee, Chang Won, Park, Ja Young, Kim, Eun Sook, Lee, Kwang Jae, Choi, Young Sik, Kim, Duk Kyu, Kim, In Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043969/
https://www.ncbi.nlm.nih.gov/pubmed/31339011
http://dx.doi.org/10.4093/dmj.2018.0274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043969/
https://www.ncbi.nlm.nih.gov/pubmed/31339011
http://dx.doi.org/10.4093/dmj.2018.0274

Ejemplares similares